Innovus PharmaceuticalsINNV 
$3.53-5.87%24h
-5.87%24h
Global rank11885
Market cap$478.65M
Change 7d-23.92%
YTD Performance-41.07%
SP500 benchmarkUnderperform
P/E-11.77
P/S0.70
Revenue$688.09M
Earnings-$43.55M
Dividend yield-
Main Sector
Healthcare
EPS for Innovus Pharmaceuticals (INNV)
Innovus Pharmaceuticals has an EPS of $-0.3. In 2022, the company made an earnings per share (EPS) of $-0.05. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for INNV
-
Value:-
EPS history for Innovus Pharmaceuticals from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.3 | 500.00% |
| 2022 | -$0.05 | -86.11% |
| 2021 | -$0.36 | -285.58% |
| 2020 | $0.193988 | - |
View the highest EPS stocks
